Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
<p><strong>Objective:</strong><br /> To assess the effect of anti-CD20 B-cell depletion with rituximab (RTX) on relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD).</p><br /> <p><strong>Methods:</strong><...
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
Elsevier
2020
|